Lotus Pharm (1795.TW) monthly revenue, September 2026
Lotus Pharm reported revenue of NT$2.77bn for September 2026, up 31.3% from the previous month and up 128.0% from a year earlier. Year-to-date revenue was NT$24.82bn, up 74.2% year on year. It ranked 7 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 2.77 | 31.3 | 128.0 |